G2B BioSolutions Denmark ApS: Financial statements 2023
CVR: 43237748
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
G2B BioSolutions Denmark ApS (CVR 43237748) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -10,098 and a net result of DKK -10,098. Equity in the 2023 report amounted to DKK 29,902. The solvency ratio was 85.7%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -10,098
- Profit/Loss
- DKK -10,098
- Equity
- DKK 29,902
- Total Assets
- DKK 34,902
- Employees
- 1
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
G2B BioSolutions Denmark ApS has published its interim report for the period May 4, 2022 – December 31, 2022.
About G2B BioSolutions Denmark ApS
G2B BioSolutions Denmark ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2022. The company has been dissolved. The company was registered under the industry Levering af kombinerede hjælpetjenester i forbindelse med drift af fast ejendom. According to the 2024 annual report, the company had an average of 0 employees. In 2024, the company reported a gross profit of DKK -9,313 and a net result of DKK -9,563 compared with DKK -10,098 the year before. Equity in the 2024 report amounted to DKK 20,340.